National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 34446 [2015-14666]
Download as PDF
<![CDATA[
34446
Federal Register / Vol. 80, No. 115 / Tuesday, June 16, 2015 / Notices
Contact Person: Inna Gorshkova, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, 301–435–1784, gorshkoi@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Fellowships:
Infectious Diseases and Microbiology.
Date: July 9–10, 2015.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Mayflower Park Hotel, 405 Olive
Way, Seattle, WA 98101.
Contact Person: Alexander D. Politis,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3210,
MSC 7808, Bethesda, MD 20892, (301) 435–
1150, politisa@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel AREA
Review: Molecular Mechanisms in
Prokaryotes, Mice and Human.
Date: July 9, 2015.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Richard Panniers, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2212,
MSC 7890, Bethesda, MD 20892, (301) 435–
1741, pannierr@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: June 11, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–14732 Filed 6–15–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
asabaliauskas on DSK5VPTVN1PROD with NOTICES
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
VerDate Sep<11>2014
17:18 Jun 15, 2015
Jkt 235001
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK–R01
Application Telephone SEP.
Date: July 8, 2015.
Time: 2:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Xiaodu Guo, MD, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 761, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–4719,
guox@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: June 10, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–14666 Filed 6–15–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
Project: Primary and Behavioral Health
Care Integration Program (OMB No.
0930–0340)—Revision
The Substance Abuse and Mental
Health Services Administration’s
(SAMHSA) Center for Mental Health
Services, (CMHS) is requesting a
revision from the Office of Management
and Budget (OMB) for data collection
activities associated with their Primary
PO 00000
Frm 00084
Fmt 4703
Sfmt 4703
and Behavioral Health Care Integration
(PBHCI) Program. Specifically,
SAMHSA is requesting approval to only
collect information on grantee quarterly
reports.
The purpose of the PBHCI grant
program is to improve the overall
wellness and physical health status of
people with serious mental illnesses
(SMI), including individuals with cooccurring substance use disorders, by
supporting communities to coordinate
and integrate primary care services into
publicly-funded community mental
health and other community-based
behavioral health settings. The
program’s goal is to improve the
physical health status of adults with
serious mental illnesses (and those with
co-occurring substance use disorders)
who have or are at risk for co-occurring
primary care conditions and chronic
diseases. The program’s objective is to
support the triple aim of improving the
health of those with SMI; enhancing the
client’s experience of care (including
quality, access, and reliability); and
reducing/controlling the per capita cost
of care.
New questions added to the quarterly
report will include information on the
selected evidence based practices (EBPs)
for nutrition and tobacco cessation
(including the number of participants
and their outcomes), identifying the
selected blood pressure treatment
protocol (one of four recommended by
the Centers for Disease Control and
Prevention), and updating the chart on
the identified sub-population(s) on
physical health indicators in the
disparities impact statement section of
the quarterly report.
This information collection is needed
to provide SAMHSA with sufficient
information to monitor grantee
performance and to assess whether
integrated primary care services
produce improvements in the physical
health of the SMI population receiving
services from community-based
behavioral health agencies.
Collection of the information
included in this request is authorized by
Section 505 of the Public Health Service
Act (42 U.S.C. 290aa–4)—Data
Collection. Authorization for the PBHCI
program is provided under Section 5604
of H.R. 3590, the Affordable Care Act
(ACA), which authorizes SAMHSA to
provide awards for the co-location of
primary and specialty care in
community-based mental health
settings.
The table below reflects the
annualized hourly burden.
E:\FR\FM\16JNN1.SGM
16JNN1
]]>Agencies
[Federal Register Volume 80, Number 115 (Tuesday, June 16, 2015)]
[Notices]
[Page 34446]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-14666]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; NIDDK-R01 Application
Telephone SEP.
Date: July 8, 2015.
Time: 2:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Xiaodu Guo, MD, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 761, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301)
594-4719, guox@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: June 10, 2015.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-14666 Filed 6-15-15; 8:45 am]
BILLING CODE 4140-01-P
